Skip to main content
Long COVID

Be part of groundbreaking Long COVID research from Scripps Research

We endeavor to conduct a portfolio of Long COVID clinical trials within our Long COVID Treatment Trial (LoCITT) program, operated by Scripps Research in partnership with CareEvolution and funded by the Schmidt Initiative for Long COVID (SILC). This work is crucial given the global burden of Long COVID, with over 400 million individuals affected, several mechanisms involved in contributing to over 200 symptoms, and no FDA approved treatments.

Current Studies

“I’m so blown away – never felt more seen by a research team than I did on this webinar. By including patients as partners in research from the ground up the team was able to proactively excel in areas that other study teams have failed. Many thanks to the Scripps Research team and to the Schmidt Initiative for setting the record straight on Long COVID research – decentralized trials are not a luxury, they are a necessity and it can be done!”

Elle Seibert
Public health research consultant, Long COVID patient and community organizer, @gotlongcovid

“I’m finally getting to watch this webinar video from the other week regarding the Scripps Long Covid treatment clinical trials. I’m only halfway through it and already I’m totally blown away by what Julia Moore Vogel has set up. This is like some kind of beautiful dream. This team is so smart and so thoughtful and doing everything right, from what I can see. It’s like everything we would wish for. It’s putting the patients first, and science first. Congratulations, Julia. Honestly, they should put you in charge of RECOVER TLC.”

Rivka

“The fact that it is being looked at is huge. This condition is scary because there are so many symptoms and doctors don’t know what to expect, so collecting this data is so important because it has the potential to be so impactful for so many people.”

Estela Mata
Long COVID user tester

About LoCITT

The Long COVID research program at Scripps has:

  • Remote participation options
  • Participants living in the U.S.
  • Real-world data collected via digital health tools

Private and Trusted

LoCITT is run by Scripps Research, a leading nonprofit academic institution with a focus on research and education in biomedical sciences. Our researchers lead breakthrough studies that address the world’s most pressing health concerns.

As a trusted nonprofit organization, your privacy is our priority. In order to protect you, your name and personal information are removed from your data prior to it reaching our researchers. 

Easy, Free and Convenient

If you live in the United States and have a smartphone, you can download the MyDataHelps™ app to participate.

Download App

Connect Devices

Share Health Records

Fill Out Surveys

Get Data and Recommendations

Join the Long COVID Treatment Trial (LoCITT) waitlist

We are beginning a waitlist of people who are interested in participating to contribute to the advancement of Long COVID and infection-associated chronic conditions research.

Join the LoCITT waitlist
Únase a la lista de espera de LoCITT

You can sign up to receive updates on our Long COVID clinical trials and be notified before a clinical trial launches.

You can be removed from the waitlist by:

  • Contacting the research team at longcovid@scripps.edu
  • You will no longer be contacted about new research opportunities

Join Our Early Experience Tester Program

We’re looking for volunteers to try out new features before they launch. Sign up to be among the first to explore the Long COVID Treatment Trial experience and help us make it better for everyone.

Sign Up

Contact Us

For questions regarding this program, please contact us by email at longcovid@scripps.edu.

Share